Wockhardt To Export 100 Million Sputnik Vaccines
News Comes Following Respectable Q3 Results For Indian Pharma Firm
Indian pharmaceutical firm Wockhardt is set to export up to 100 million doses of the Russian COVID-19 vaccine Sputnik V, through a technology transfer agreement with the Gamaleya National Research Institute of Epidemiology and Microbiology.
